Prednisolone-loaded albumin nanospheres: In vitro and in vivo evaluation studies

PDA Journal of Pharmaceutical Science and Technology

Volumn 62, Issue 2, 2008, Pages 111-124

  Kapoor, Deepak N ^a   Manvi, Fakirappa V ^b   Doijad, Rajendra C ^b   Dhawan, Sanju ^a  

^a PANJAB UNIVERSITY   (India)

^b K L E S S COLLEGE OF PHARMACY   (India)

Author keywords

Albumin; Coacervation; Nanospheres; Organ targeting; Prednisolone

Indexed keywords

BOVINE SERUM ALBUMIN; NANOSPHERE; PREDNISOLONE; DRUG CARRIER; GLUCOCORTICOID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIFFUSION; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG LIVER LEVEL; DRUG RELEASE; DRUG TISSUE LEVEL; IN VITRO STUDY; IN VIVO STUDY; LUNG; MOUSE; NONHUMAN; PARTICLE SIZE; SPLEEN; ANIMAL; CATTLE; CHEMISTRY; LIVER; METABOLISM; PH; TISSUE DISTRIBUTION;

ANIMALS; CATTLE; DIFFUSION; DRUG CARRIERS; GLUCOCORTICOIDS; HYDROGEN-ION CONCENTRATION; LIVER; LUNG; MICE; NANOSPHERES; PARTICLE SIZE; PREDNISOLONE; SERUM ALBUMIN, BOVINE; SPLEEN; TISSUE DISTRIBUTION;

EID: 45949106952     PISSN: 10797440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Muller, G. B.; Leuenberger H.; Kissel T. Albumin nanospheres as carriers for passive drug targeting: An optimized manufacturing technique. Pharm. Res. 2006, 13 (1), 32-37.
2. Lee, T. K.; Sokoloski, T. D.; Royer, G. P. Serum albumin beads: an injectable, biodegradable system for the sustained release of drugs. Science 1981, 213 (4504), 233-235.
3. Weber, C.; Reiss, S.; Langer, K. Preparation of surface modified protein nanoparticles by introduction of sulfhydryl groups. Int. J. Pharm. 2000, 211, 67-78.
4. Alonso, M. J. Nanoparticulate Drug Carrier Technology. In Microparticulate Systems for the Delivery of Proteins and Vaccines, Cohen, A., Bernstein, H., Eds. Marcel Dekker, Inc.: New York, 1996; Vol. 77, pp 203-242.
5. Santhi, K.; Dhanaraj, S. A.; Rajendran, S. D.; Raja, K.; Ponnusankar, S.; Suresh, B. Nonliposomal approach - a study of preparation of egg albumin nanospheres containing amphotericin-B. Drug Dev. Ind. Pharm. 1999, 25 (4), 547-551.
6. 14C] methacrylate) nanoparticles radioactivity after injection in rats and mice. J. Pharm. Sci. 1979, 68, 1443-1447.
7. Illum, L.; Davis, S. S.; Wilson, C.; Thomas, N.; Frier, M.; Hardy, J. Blood clearance and organ deposition of intravenously administered colloidal particles - the effect of particle size, nature and shape. Int. J. Pharm. 1982, 12, 135-146.
8. Grislain, L.; Couvreur, P.; Lenaerts, V.; Roland, M.; Deprez Decampeneere, D.; Speicer, P. Pharmacokinetics and distribution of a biodegradable drug carrier. Int. J. Pharm. 1983, 15, 335-345.
9. Merodio, M.; Arnedo, A.; Renedo, M. J.; Irache, J. M. Ganciclovir-loaded albumin nanoparticles: characterization and in-vitro release properties. Eur. J. Pharm. Biopharm. 2001, 12, 251-259.
10. Arnedo, A.; Espuelas, S.; Irache, J. M. Albumin nanoparticles as carriers for a phospho-di-ester oligonucleotide. Int. J. Pharm. 2002, 244, 59-72.
11. Kreuter, J. Evaluation of nanoparticles as drug delivery systems. I. Preparation method. Pharm. Acta Helv. 1983, 58, 196-209.
12. Gallo, J. M.; Hung, C. T.; Perrier, D.G. Analysis of albumin microsphere preparation. Int. J. Pharm. 1984, 22, 63-74.
13. Lin, W.; Coombes, A. G. A.; Davies, M. C.; Davis, S. S.; Ilum, L. Preparation of sub-100 M, human serum albumin nanospheres using a pH-coacervation method. J. Drug Targeting 1993, 1, 237-243.
14. Santhi, K.; Dhanaraj, S. A.; Ponnusankar, S.; Suresh, B. Study on formulation and targeting efficiency of amphotericin-B nanospheres. Indian J. Pharm. Sci. 2000, 6, 421-423.
15. Kreuter, J. Evaluation of nanoparticles as drug-delivery systems. II. Comparison of the body distribution of nanoparticles with the body distribution of microspheres (diameter greater than1 micron) liposomes, and emulsions Pharm. Acta Helv. 1983, 58 (8), 217-226.
16. Parfitt, K., Ed. Corticosteroids. In Martindale - The Complete Drug Reference, 32nd ed.; Pharmaceutical Press: London, 1999; p 1010.
17. Schimmer, B. P.; Parker, K. L. Adrenocorticotropic Hormone: Adrenocortical Steroids and Their Synthetic Analogs. In Hardman, J. G., Limbird, L. E., Eds. Goodman & Gilman's The Pharmacological Basis of Therapeutics, 10th ed; McGraw Hill Companies, Inc.: New York, 2001; p 1655.
18. Weber, C.; Coester, C.; Kreuter, J.; Langer, K. Desolvation process and surface characterisation of protein nanoparticles. Int. J. Pharm. 2000, 194, 91-102.
19. Kreuter, J. Physicochemical characterization of polyacrylic nanoparticles. Int. J. Pharm. 1983, 14, 43-58.
20. Govender, T.; Stolnik, S.; Garnett, M. C.; Illum, L.; Davis, S. S. PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water-soluble drug. J. Controlled Release 1999, 57, 171-185.
21. Polli, J. E.; Rekhi, G. S.; Shah, V. P. Methods to compare dissolution profiles, Drug Info. J. 1996, 30, 1113-1120.
22. Korsmeyer, R. W.; Peppas, N. A. (1985), Analysis of Fickian and non-Fickian drug release from polymers. Pharma. Acta Helv. 1985, 60, 110-111.
23. Mordenti, J. Dosage regimen design for pharmaceutical studies conducted in animals, J. Pharm. Sci. 1986, 75, 852-857.
24. Gorog, S.; Szasz, G. Chapter 6. Prednisolone. In Analysis of Steroid Hormone Drugs; Elsevier: USA, 1978; pp 173-273.
25. Narurkar, A. N.; Jarowski, C. I. Modified colorimetric method for plasma prednisolone, Journal of Pharmaceutical Sciences 1981, 70 (7), 810-811.
26. Bhadra, S.; Chaubey, P.; Bhadra, D.; Agarwal, G. P., Target oriented microspheres of diclofenac sodium. Indian J. Pharm. Sci. 2000, 65 (5), 503-509.
27. Cognar, M., Kos, J., Kristl, J., Cystatin incorporated in PLGA nanoparticles: Development and fundamental studies on preservation of its activity. Eur. J. Pharm. Sci. 2004, 22, 357-364.
28. Rolland, A.; Bourel, D.; Genetet, B.; Verge, R. L. Monoclonal antibodies covalently coupled to polymethacrylic nanoparticles: in-vitro specific targeting to human T-lymphocytes. Int. J. Pharm. 1987, 39, 173-180.
29. Yoshioka, J.; Hashida, M.; Muranishi, S.; Sezaki, H. Specific delivery of mitomycin C to the liver, spleen and lung: nano and microspherical carriers of gelatin. Int. J. Pharm. 1981, 81, 131-141.